Keyword: Press release

This page displays contents related to the keyword.

US Department of Defense Supports Breast Cancer Research at the Turku Bioscience Centre

27.04.2020

Despite of continuous development in breast cancer treatments, metastases of the most aggressive breast cancer types are still a significant and growing medical problem. Together with a research group at Michigan University, the group of Professor Jukka Westermarck at Turku Bioscience Centre recently received funding from the US Department of Defense for the development of novel treatment strategies for breast cancer metastases.

Dietary Counselling Introduced at an Early Age Leads to Better Cardiovascular Health in Adulthood

23.04.2020

The Special Turku Coronary Risk Factor Intervention Project investigated the long-term effects of dietary counselling on cardiovascular health. The individuals, who had participated in the trial between ages 7 months and 20 years, were invited to a follow-up study at the age of 26. The results show that the intervention group who received dietary counselling had lower serum cholesterol level and better insulin sensitivity than those in the control group.

A new digital toolkit to help children with Corona Anxiety

17.04.2020

The Department of Child Psychiatry has opened a website for parents whose children develop symptoms of anxiety or fear during the current corona epidemic. The website provides information on anxiety, advice on how to handle difficult feelings and simple exercises to ease the anxiety of a parent and their child. The site has been implemented by experienced digital care researchers.

Missing BAP1 Gene Is Associated with Immunosuppressive Molecules in Uveal Melanoma

09.04.2020

New study from researchers in Finland and the United Kingdom reveals that tumors lacking a protein called BAP1 have an ineffective immune reaction against cancer, thus rendering immunotherapies ineffectual, particularly in uveal melanomas (UM). The researchers also discovered that when BAP1 is lost, other molecules will be present in order to support cancer growth. Luckily, some of these molecules can be targeted with existing drugs, which can lead to the development of novel immunotherapies.